Mean concentration of folliculostimulating hormone was higher in patients who received adjuvant radiotherapy
in comparison to patients who received only surgical treatment -94.
These lesions are thought to respond best to complete surgical excision (if possible, given the complex anatomy of the region) with adjuvant radiotherapy
for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term followup of a randomized clinical trial.
Current clinical practice guidelines from the American Urological Association (AUA) and the American Society for Radiation Oncology (ASTRO) recommend physicians offer adjuvant radiotherapy
after surgery for men who have been diagnosed with intermediate and high-risk prostate cancer.
In a retrospective study of almost 200,000 women with breast cancer, those who received adjuvant radiotherapy
were at a 16-fold increased risk for development of angiosarcoma (9).
2004) suggest that adjuvant radiotherapy
in breast conservative surgery patients should not be unnecessarily delayed and certainly should not commence later than 20 weeks following surgery.
may also be used post-operatively, however Chordomas are relatively radio-resistant and the value of radiotherapy in their treatment is still a matter of debate.
Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy
for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
Surgery and adjuvant radiotherapy
vs concurrent chemoradiotherapy in stage III/IV non metastatic squamous cell head and neck cancer: a randomized comparison.
None of the 34 women who had low breast density and who did not receive adjuvant radiotherapy
developed a recurrence, suggesting that they were not harmed by foregoing radiotherapy.
6 years, neither disease-free survival (DFS) nor overall survival (OS) was related to surgery with respect to menstrual cycle, even in data analyses that accounted for nodal disease, hormone receptor status and adjuvant radiotherapy
and chemotherapy in nodepositive premenopausal women with breast cancer.